Investigate Novel Therapeutic Interventions and Testing Strategies for Neurological Disorders Including to Treat, Modify and Prevent the Development of Epilepsy (U24 Clinical Trial Not Allowed)

National Institute of Neurological Disorders and Stroke (NINDS) · NIH Institute/Center · RFA-NS-26-002

Source: Grants.gov · View original posting ↗

AwardWhat a single award can be worth — the funder's published per-award amount or floor–ceiling range.

Amount not listed

DeadlineFinal application due date.

Not yet posted

Letter of intentDue date for the letter of intent (a short pre-application some funders require or request before the full proposal).

—

MechanismNIH activity code — the grant type (R01 research project, R21 exploratory, K series career development, F series fellowship, …).

U24

DurationMaximum project period for a single award.

—

Expected awardsHow many awards the funder anticipates making under this opportunity.

—

Funding cycleHow often the program accepts applications (annual, multiple cycles per year, rolling, or one-time).

One-time

Open dateWhen applications open (or opened).

Sep 23, 2025

Total fundingThe overall pool the funder expects to commit across ALL awards under this opportunity — not what one project receives.

—

Clinical trialWhether proposed projects must, may, or must not include a clinical trial.

Not allowed